177 evolution-"https:"-"https:"-"https:"-"https:"-"https:"-"Iscte-IUL" positions at NIST
Sort by
Refine Your Search
-
characterize, manufactured particles suffer heterogeneity issues which hinder treatment efficacy and safety. To speed treatment development and improve efficacy and safety we are developing interferometric
-
), in the CODATA evaluation of fundamental constants, and in more stringent tests of quantum electrodynamics (QED). Experimental efforts include the development of novel ion trap architectures
-
will have opportunities for participation in instrument/technique development projects. key words Radionuclide metrology; Digital data acquisition; Si(Li) detector; HPGe detector; Coincidence counting
-
been in development over the past 15+ years and their capabilities have grown significantly. An important effort within the LPBF community is the use of high-fidelity multiphysics models to predict melt
-
key component at this stage will be the development of quantum characterization protocols for spin qubits in the presence of time-correlated noise, as well as reliable tools for simulating the quantum
-
LC-MS/MS instruments and custom software tools. Individuals with a background in proteomic sample preparation, mass spectrometry, and software development are encouraged to apply as well those who have
-
on fundamental constants in the development of quantum electrical standards. The FEM group uses physical laws, quantum invariants, and ultra-precision measurement techniques to create and refine a core set of
-
) to characterize the nuclear motions associated with the observed THz features. New methods based on electro-optical dual-optical-frequency combs and room-temperature multi-heterodyne detection are under development
-
properties. While our focus is on industrially important fluids, such as fuels and refrigerants, we also welcome proposals that would yield data primarily intended for model development, such as studies
-
NIST only participates in the February and August reviews. The development of therapies and other products based on pluripotent stem cells requires control of the pluripotent and differentiated